On Air Now

The Sean Show

6:00pm - 8:00pm

Now Playing

First tablet version of weight-loss jabs to be available in UK in weeks

Thursday, 11 June 2026 17:49

By Thomas Moore, science correspondent

The first tablet version of the blockbuster weight-loss jabs will be available in the UK within weeks, following approval by the medicines regulator.

The daily Wegovy Pill contains the same active ingredient as the weekly injection, and is almost as effective, with users losing on average of just under 14% of their body weight over 64 weeks.

As well as the attraction of being needle-free, it is expected to be cheaper than the jab, though manufacturer Novo Nordisk will not confirm a UK price.

It will only be available with a private prescription and won't be available on the NHS until it has been reviewed for cost effectiveness by the medicines' watchdog NICE.

Professor Naveed Sattar, Professor of Cardiometabolic Medicine at the University of Glasgow, said: "The approval of the once-daily oral form of Wegovy is welcome news for people living with obesity, particularly those who would prefer not to use injections.

"With obesity rates in the UK now at very high levels, and associated with substantial multimorbidity, additional treatment options for sustained weight loss are greatly needed."

An estimated 1.6million people have used injected versions of Wegovy or its competitor Mounjaro in the last year. Only a tiny fraction of them are prescribed the drug on the NHS.

But approval by the Medicines and Healthcare products Regulatory Agency (MHRA) of a tablet formulation is expected to result in a surge in demand. Online pharmacy Chemist4U says it already has a waiting list of more than 10,000 customers.

Eli Lilly, which makes Mounjaro, is expected to win approval for a tablet version later this year.

Read more:
Fuel running dry in Russian-held Crimea
Police push tech firms to make stolen phones unusable

Emil Kongshoj Larsen of Novo Nordisk said the UK is the first country in Europe to approve the pill version of Wegovy.

"Around 15 million people in the UK are living with obesity, yet only a small proportion of them have access to treatment and we hope this approval supports increasing access to obesity care in the UK," he said.

"With the introduction of this option for weight management, we have an opportunity to support many more eligible patients. Most importantly, this gives patients another option - one that may fit their lives and help them reach their health goals."

Sky News

(c) Sky News 2026: First tablet version of weight-loss jabs to be available in UK in weeks

Donate to Roch Valley Radio

 

Do you have a story for us? Want to tell us about something happening in our Borough?

Let us know by emailing newsdesk@rochvalleyradio.com

All contact will be treated in confidence.

More from UK

Donate to Roch Valley Radio

 

Recently Played

Newsletter

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter and stay updated.

   

Coming up next On Air

  • The Sean Show

    6:00pm - 8:00pm

    Sean Cummiskey brings you the The Sensational Spectacular Sctillating Supersonic Sean Show! Or for ease The Sean Show! Top music and musings with “Great Number 2’s” and the home of tenuous links to songs from the news and “on this day!”.

  • The Midnight Special

    8:00pm - 10:00pm

    Craig, Christian and Tony bring a mix of songs & genres & nonsense, from brand new to classic.

  • Ben

    10:00pm - Midnight

    With Ben Chuvali

  • After Hours

    Midnight - 2:00am

    For the night owls, night workers and everyone still going while the rest of the town sleeps. Music, chat and company after dark.

  • Wide Awake Club

    2:00am - 5:00am

    For those who find themselves awake at 3am more often than they’d like. Calm music, understanding voices and quiet company.

  • Up Before the Alarm

    5:00am - 7:00am

    for early starters, commuters and anyone already on their second brew. Livelier music and new voices warming things up before breakfast.